Jérôme MOREAUX
6Patents
1h-index
10Co-inventors
40Inventor score
Filing activity: Oct 8, 2013 → Feb 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10676791B2 | Methods for predicting response to DNA repair pathway inhibitors in diffuse large B-cell lymphoma | Physics | 2 | Active |
| US12071671B2 | Methods for the in vitro determination of the outcome and for the treatment of individuals having multiple myeloma | Chemistry; Metallurgy | 0 | Active |
| US11499197B2 | Prognosis method of multiple myeloma | Chemistry; Metallurgy | 0 | Active |
| US10174380B2 | Methods for predicting multiple myeloma treatment response | Chemistry; Metallurgy | 0 | Active |
| US11578369B2 | Method for the in vitro prognosis of individuals having multiple myeloma and method for the treatment thereof | Chemistry; Metallurgy | 0 | Active |
| US10662481B2 | Methods for predicting response to HDACi/DNMTi combination in multiple myeloma | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.